In this third entry on the Use of Oral Oncolytics in Palliative Care, part of the Oncology Stakeholders Summit, Spring 2015 series, Bruce A. Feinberg, DO, and Brian B. Kiss, MD, address issues in introducing the palliative care plan to the patient and the family.
Dr Kiss, vice president, healthcare transformation, Blue Cross Blue Shield of Florida, believes it is critical that the patient’s family be involved in palliative care decisions, and they try to fully understand and come to terms with their relative’s priorities. As many patients do not usually discuss their wishes at the end of life, Dr Kiss believes that their desires should be made clear early on to everyone involved.
With regard to physicians’ having palliative care discussions with their patients, Dr Feinberg states that it can very difficult for clinicians to have these end-of-life conversations in the office, perhaps after just showing the patient a CT scan of his or her advancing disease and under the practice’s time pressures. The vice president and chief medical officer at Cardinal Health Specialty Solutions describes the need to have the right physician or “a licensed clinical social worker certified in palliative care counseling spend 90 minutes having that conversation, with the family present.” Explaining the patient’s options at the appropriate time, and spending the time needed to thoroughly discuss these options, is extremely important, with other friends or family members on hand to lend support.
Perhaps clinicians should have 2 separate end-of-life conversations, according to Dr Kiss. First, one with the patient, to allow him or her to formulate ideas about what to do. Then, a second conversation with the family after the patient has had time to consider his or her own options.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Coexistence of HIV, Hemophilia May Lead to Increased Presence of Coronary Artery Stenosis
May 8th 2024In patients living with HIV, the cardiovascular risk factors that come with infection may lead to an increased prevalence of coronary artery stenosis, especially in those who also have hemophilia.
Read More
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More